$CSOL is positioning itself at the intersection of AI and content testing. After acquiring Alyze AI Metrics, the company is developing webcam-based tools that measure emotional reactions and attention in real time. The approach is designed to be accessible — no specialized labs or hardware required — which could make it practical for studios, advertisers, and brands. They’ve disclosed ongoing discussions with major content creators about potential pre-release evaluations of films, trailers, and campaigns, and they’re advancing a commercialization roadmap while planning a name change to Alyze AI Inc. At a sub-$2M market cap, the stock remains priced for limited success. Execution on even modest commercial progress would be a notable shift for a name this size. High-risk High-reward OTC setup, but the core concept is straightforward. #CSOL #AlyzeAI #AI #AudienceTesting @Alyze_AI @SuperRobotGX @og_tigress

$CVAT closed Friday at $0.032. Cap about ~$11M. The BrightFlixx cash tender is live. Schedule TO-T is on EDGAR. Concurrent Alchemy offer. The math is still there: • $35M net aggregate for CVAT (less liabilities on the Record Date) • Initial estimate: ~$0.105 • Record Date: December 24, 2026 • Initial expiration: January 26, 2027 That’s roughly a 3x gap from Friday’s close to the current estimate. Final price depends on shares and liabilities on the Record Date, and the deal still needs 90% tenders (waivable), CFIUS, and both offers to clear. But the offer is open, the paperwork is filed, and the clock is running. $CVAT #CVAT #OTC #OTCQB #Pennystocks #Stocks #NanoTech #WaterTech @SuperRobotGX

$CSOL is turning a simple idea into a real product: what if every webcam could act like a focus group? Through Alyze AI Metrics, the company is commercializing AI that reads emotional response and attention in real time from ordinary webcams. No labs. No special gear. Just cloud-based analysis that studios, marketers, and brands can actually use at scale. They’re already in discussions with major content creators about potential pre-release testing for films, trailers, and campaigns, and they’ve outlined the next steps on their commercialization roadmap. The planned shift to Alyze AI Inc. would clean up the story even further. Still a sub-$2M OTC name with all the usual risks. But the core tech is accessible, the market is large, and the valuation leaves room if they start converting interest into traction. #CSOL #AlyzeAI #AudienceIntelligence #OTC @SuperRobotGX @Alyze_AI @buffalofireside @og_tigress @KickoStocks